Insight Molecular - IMDX Company Short-Term Debt

imdxinc.com (IMDX) - corporate logo

Insight Molecular Diagnostics (IMDX) relies on a strong staff of biochemists and geneticists while attracting experienced managers. The company's developments in DNA analysis lay the foundation for personalized patient treatment. Revenues are generated through high-precision oncology tests. Short-term loan capital visualizes the current debt load, while the value of 0.00 reflects the balance of the issuer's solvency metric.

IMDX (Insight Molecular Diagnostics) Company Short-Term Debts history from 06/19/2025 to 10/28/2026

Insight Molecular Diagnostics, Inc. - analytical breakdowns and key metrics (IMDX)

- price and consensus price forecast:
Stock Price Insight Molecular|IMDX - Analyst Consensus Forecast
- market capitalization data:
Market Value Insight Molecular Diagnostics Inc|IMDX - Business Value
- book capitalization data:
Book Value per Share Insight Molecular Diagnostics|IMDX - Book Capitalization|Market Value to Book Value Ratio imdxinc.com|IMDX - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Insight Molecular Diagnostics|IMDX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Insight Molecular|IMDX - Company Total Debt Obligations|Debts to Book Capitalization Insight Molecular Diagnostics Inc|IMDX - Long-Term Debt Volume|Company Short-Term Debt Insight Molecular Diagnostics
Analysis of all company metrics:imdxinc.com IMDX
Finished products of Insight Molecular

Total financial liabilities with a maturity of up to one year, amounting to 0.00, measure the pressure on operating liquidity and determine the issuer's ability to service current loans. For Insight Molecular Diagnostics (IMDX), which is currently in the commercial launch phase of its molecular tests, the current level of short-term debt demonstrates capital management efficiency amidst high unit costs before achieving economies of scale.

Competitor analysis for Insight Molecular Diagnostics

Agilent - Company Short-Term Debts|DGX: Company Short-Term Debts|Company Short-Term Debt Illumina Corp|Exact Sciences Inc. (EXAS) - Company Short-Term Indebtedness|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts BIO|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt Sotera Health Corp SHC|QDEL: Company Current Liabilities|OPKO Health Corp. - Short-Term Debt|Company Short-Term Debt CDNA (CareDx, Inc.)|MRVI - Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debts|LAB (Standard BioTools Inc) - Short-Term Debt Volume|CTKB: Company Short-Term Debt|Short-Term Debt Volume OraSure Corp|XGN (Exagen Inc.) - Company Short-Term Debts|Short-Term Debt Volume MDXH (mdxhealth.com)|LUCD - Company Short-Term Debt|Prenetics Global Limited - Company Short-Term Indebtedness|Company Short-Term Debt TRIB (Trinity Biotech Corp)|PRPH - Short-Term Debt Volume|Ainos, Inc. - Company Short-Term Debts|codiagnostics.com (CODX) - Short-Term Debt Volume|HeartSciences - Company Short-Term Debts|Short-Term Indebtedness Biomerica Inc.|Cardio Diagnostics (CDIO) - Company Short-Term Debts|Company Short-Term Loans and Borrowings Virax Biolabs Corp VRAX|Company Current Liabilities Bluejay Diagnostics (BJDX)|AWH - Amount of Current Liabilities|Company Current Liabilities Accelerate Diagnostics, Inc. (AXDX)|CNTG: Company Short-Term Loans and Borrowings|ENZ (enzo.com) - Company Short-Term Debt|FRES (Fresh2 Group) - Company Current Liabilities|Company Short-Term Debt GENE (Genetic Technologies Ltd)|Short-Term Debt ME|Company Short-Term Debt Psychemedics Corporation (PMD)